SI2260053T1 - Analogi oksitocina - Google Patents

Analogi oksitocina

Info

Publication number
SI2260053T1
SI2260053T1 SI200930966T SI200930966T SI2260053T1 SI 2260053 T1 SI2260053 T1 SI 2260053T1 SI 200930966 T SI200930966 T SI 200930966T SI 200930966 T SI200930966 T SI 200930966T SI 2260053 T1 SI2260053 T1 SI 2260053T1
Authority
SI
Slovenia
Prior art keywords
oxytocin analogues
oxytocin
analogues
Prior art date
Application number
SI200930966T
Other languages
English (en)
Slovenian (sl)
Inventor
Sudarkodi Alagarsamy
Robert Galyean
Kazimierz Wisniewski
Claudio Schteingart
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39722695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2260053(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of SI2260053T1 publication Critical patent/SI2260053T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SI200930966T 2008-03-31 2009-03-30 Analogi oksitocina SI2260053T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4097308P 2008-03-31 2008-03-31
EP08251739 2008-05-19
PCT/IB2009/005351 WO2009122285A1 (en) 2008-03-31 2009-03-30 Oxitocin analogues
EP09727031.8A EP2260053B1 (en) 2008-03-31 2009-03-30 Oxytocin analogues

Publications (1)

Publication Number Publication Date
SI2260053T1 true SI2260053T1 (sl) 2014-08-29

Family

ID=39722695

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930966T SI2260053T1 (sl) 2008-03-31 2009-03-30 Analogi oksitocina

Country Status (20)

Country Link
US (1) US8673841B2 (OSRAM)
EP (2) EP2260053B1 (OSRAM)
JP (1) JP5539310B2 (OSRAM)
KR (1) KR101558404B1 (OSRAM)
CN (1) CN101983205B (OSRAM)
AU (1) AU2009233429B2 (OSRAM)
BR (1) BRPI0910345B1 (OSRAM)
CA (1) CA2718148C (OSRAM)
DK (1) DK2260053T3 (OSRAM)
ES (1) ES2488992T3 (OSRAM)
HR (1) HRP20140716T1 (OSRAM)
IL (1) IL208039A (OSRAM)
MX (1) MX2010010743A (OSRAM)
NZ (1) NZ587817A (OSRAM)
PL (1) PL2260053T3 (OSRAM)
PT (1) PT2260053E (OSRAM)
RU (1) RU2496788C2 (OSRAM)
SI (1) SI2260053T1 (OSRAM)
WO (1) WO2009122285A1 (OSRAM)
ZA (1) ZA201006733B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011147889A1 (en) 2010-05-25 2011-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
DK2935312T3 (en) 2012-12-21 2018-10-22 Hoffmann La Roche Peptides as oxytocin agonists
CA2949173A1 (en) * 2014-06-03 2015-12-10 Caterina Bissantz Peptides as oxytocin agonists
CR20160562A (es) * 2014-06-06 2017-01-06 Hoffmann La Roche Péptidos como agonistas de la oxitocina
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
FI3666258T3 (fi) * 2014-09-19 2024-02-09 Ferring Bv Menetelmä prader-willin oireyhtymän hoitamiseksi
CN106084015B (zh) * 2016-08-25 2020-01-31 成都圣诺生物制药有限公司 一种合成卡贝缩宫素的方法
WO2019032946A1 (en) 2017-08-11 2019-02-14 Ferring B.V. PROCESS FOR PRODUCING OXYTOCIN
WO2019030412A1 (en) * 2017-08-11 2019-02-14 Ferring B.V. PROCESS FOR PRODUCING PHARMACEUTICAL PREPARATION
CN107628975B (zh) * 2017-09-17 2019-10-29 贵州医科大学 赖氨酸衍生物类组蛋白去乙酰化酶抑制剂及其合成和应用
CN112969450B (zh) 2018-09-20 2023-05-30 阿卡蒂亚药品公司 卡贝缩宫素药物产品及用于制备其的方法
CA3112185C (en) 2018-09-20 2025-10-07 Acadia Pharmaceuticals Inc. STABLE INTRANASAL FORMULATIONS OF CARBETOCINE
WO2020137880A1 (ja) * 2018-12-27 2020-07-02 国立大学法人北海道大学 オキシトシン誘導体及びその使用
JP2023500763A (ja) * 2019-11-04 2023-01-11 フェリング ベスローテン フェンノートシャップ 泌乳の改善のためのメロトシンの鼻腔内投与
US20230265124A1 (en) * 2020-07-27 2023-08-24 Az. Bd. of Reg. on Behalf of the Univ. of Arizona Oxytocin analogues and methods for using the same
EP4313106B1 (en) 2021-03-26 2025-01-15 Ot4B Treatment of dysphagia
WO2024044633A2 (en) * 2022-08-23 2024-02-29 Seattle Children's Hospital (D/B/A Seattle Children's Research Institute) Oxytocin derivatives and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
EP1480998B1 (en) * 2002-02-27 2006-11-22 Ferring BV Intermediates and methods for making heptapeptide oxytocin analogues

Also Published As

Publication number Publication date
MX2010010743A (es) 2010-11-04
WO2009122285A8 (en) 2009-12-10
WO2009122285A1 (en) 2009-10-08
JP2011516460A (ja) 2011-05-26
AU2009233429B2 (en) 2014-02-13
US20110044905A1 (en) 2011-02-24
KR20110005705A (ko) 2011-01-18
AU2009233429A1 (en) 2009-10-08
EP2260053B1 (en) 2014-05-14
BRPI0910345A2 (pt) 2015-10-06
CN101983205B (zh) 2015-08-19
IL208039A (en) 2016-03-31
EP2626364A1 (en) 2013-08-14
IL208039A0 (en) 2010-12-30
JP5539310B2 (ja) 2014-07-02
PL2260053T3 (pl) 2014-11-28
HRP20140716T1 (hr) 2014-08-29
ES2488992T3 (es) 2014-09-01
RU2496788C2 (ru) 2013-10-27
DK2260053T3 (da) 2014-06-23
RU2010139634A (ru) 2012-05-10
NZ587817A (en) 2012-05-25
PT2260053E (pt) 2014-08-29
CA2718148A1 (en) 2009-10-08
KR101558404B1 (ko) 2015-10-08
CA2718148C (en) 2017-11-07
US8673841B2 (en) 2014-03-18
HK1146064A1 (en) 2011-05-13
CN101983205A (zh) 2011-03-02
EP2260053A1 (en) 2010-12-15
BRPI0910345B1 (pt) 2021-08-17
ZA201006733B (en) 2011-06-29

Similar Documents

Publication Publication Date Title
IL208039A0 (en) Oxytocin analogues
ZA201104592B (en) Glucagon analogues
IL213478A0 (en) Glucagon analogues
IL213477A0 (en) Glucagon analogues
ZA201104591B (en) Glucagon analogues
EP2280616A4 (en) BODY FOR BABY
EP2278675A4 (en) SPOUT
EP2276132A4 (en) SPOUT
EP2284970A4 (en) SPOUT
EP2276134A4 (en) GROMMET
EP2285758A4 (en) DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
GB2479441B (en) Coelenterazine analogues
EP2276133A4 (en) SPOUT
EP2248703A4 (en) PASS CABLE
GB2488742B (en) Jigsaw
TWI368572B (en) Printing-table arrangement
EP2285379A4 (en) ANALOGUES OF 1-METHYLNICOTINAMIDE
GB0820166D0 (en) Former
GB2463042B (en) Stabalizer arrangement
AU3972P (en) Tobruk xTriticosecale
AU3935P (en) DPV308 Dianella prunina
AU4098P (en) NPW2 Dianella tasmanica
GB0805372D0 (en) Pathfinder
GB0805969D0 (en) Clevertee pro
GB0810438D0 (en) Case